SUBSCRIBE
SUBSCRIBE
News   FDA

Actelion Ltd.'s (JOBS) Tracleer Gets US Approval for Wider Use

August 10, 2009 | 
1 min read
Bookmark and Share

Reuters -- Europe's biggest biotech company Actelion Ltd said on Monday its Tracleer drug had been granted approval for mildly symptomatic pulmonary arterial hypertension (PAH).
FDA Approvals
MORE ON THIS TOPIC
A plus grade in the notebook
diabetes
Lilly’s Foundayo posts ‘outstanding’ diabetes data, possibly easing FDA safety concerns
April 16, 2026
 · 
2 min read
 · 
Gabrielle Masson
Drug Development
Whitepaper: CDMOs at a Crossroads
April 15, 2026
 · 
1 min read
 · 
BioSpace Insights
speed bumps marked in yellow on a residential road. a road in the fog among very old historic willows. a foggy road on a spring morning.
Obesity
Lilly’s new obesity pill linked to ‘serious’ safety signals, FDA requests more data
April 15, 2026
 · 
2 min read
 · 
Tristan Manalac
Podcast
J&J targets $100B revenue, Replimune rebuffed again and a “Revolution” in pancreatic cancer
April 15, 2026
 · 
1 min read
 · 
Heather McKenzie